Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered question first ministerially corrected answering member label previous answer version answering member printed answering member label
tabling member	label

Search

164499

	registered interest
	date	24/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Negligence
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government by how much the provision for clinical negligence claims against the National Health Service has grown in the last year; why it has grown; and what strategy is in place for reducing that amount.
	tabling member printed	Lord Sharkey
	uin	HL3092
	answer	answer is ministerial correction date of answer 04/12/2014 answer text <p>As at 31 March 2014, the National Health Service Litigation Authority (NHS LA) estimates that it has potential liabilities of £26.1 billion, of which £25.7 billion relates to clinical negligence. This is an increase of £3.1 billion from 31 March 201<del class="ministerial">4<ins class="ministerial">3</ins></del>, which can mainly be attributed to a continual rise in clinical negligence claims over recent years. There are a number of factors driving this increase, including the rise in the number of patients cared for and in the complexity of their care; and the general rise in litigation across a number of sectors including the NHS, driven in part by ‘no win, no fee’ agreements. It is anticipated that the effect of the latter is likely to diminish as a result of the Government’s Legal Aid Sentencing and Punishment of Offenders Act of 2012.</p><p> </p><p>The Department believes the best way to reduce negligence claims is to improve patient care and safety. In March 2014, the Secretary of State for Health issued a call to action to make the NHS the safest healthcare system in the world and achieve a three-year goal to halve avoidable harm and save 6,000 lives. The Sign up to Safety campaign embodies the ambition of the NHS to build a culture of safety, bringing together individuals and organisations with a contribution to make towards the patient safety goal. Elements of this campaign will focus on a reduction in avoidable harm that can lead to compensation claims. Organisations that sign up are setting out what they will do to strengthen patient safety, including a safety improvement plan which shows how their organisation intends to save lives and reduce harm for patients over the next three years. The NHS Litigation Authority, which already provides a “safety and learning service” to trusts<strong>,</strong> will support those organisations which have patient safety improvement plans that show a likely reduction in their higher volume, higher value claims.</p><p> </p> answering member printed Earl Howe question first answered 04/12/2014 16:04:05 question first ministerially corrected 13/01/2015 14:37:59 answering member 2000 label Biography information for Earl Howe previous answer version 31769 answering member printed Earl Howe answering member 2000 label Biography information for Earl Howe
	tabling member	4196 label Biography information for Lord Sharkey

157068

	registered interest
	date	20/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Orphan Drugs
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government how they propose to make available for prescription under the National Health Service orphan and ultra-orphan drugs for the treatment of rare diseases now emerging as a result of recent research discoveries.
	tabling member printed	Lord Walton of Detchant
	uin	HL3013
	answer	answer is ministerial correction date of answer 04/12/2014 answer text <p>It is for clinicians to make prescribing decisions based on their patients’ individual clinical needs.</p><p> </p><p> </p><p> </p><p>The National Institute for Health and Care Excellence (NICE) has recommended a number of drugs, designated by the European Union as orphan drugs, in technology appraisal guidance. NICE is also responsible for the evaluation of selected high cost, low volume drugs under its Highly Specialised Technologies Programme.</p><p> </p><p> </p><p> </p><p>National Health Service commissioners are legally obliged to provide funding for drugs that have been recommended in NICE technology appraisals or highly specialised technologies evaluations.</p><p> </p><p> </p><p> </p><p>We are commissioning an external review of the pathways for the development, assessment, and adoption of innovative medicines and medical technology. This review will consider how to speed up access for NHS patients to cost-effective new diagnostics, medicines and devices.</p><p> </p> answering member printed Earl Howe question first answered 04/12/2014 12:17:47 answering member 2000 label Biography information for Earl Howe
	tabling member	1716 label Biography information for Lord Walton of Detchant

164224

	registered interest
	date	21/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Rare Diseases
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what discussions they have had with NHS England about improving the process involved in assessing medicines used for treating rare diseases as described in the recent Genetics Alliance UK Patient Charter <i>Patients and Priorities of NHS England's commissioning of medicines for rare diseases</i>.
	tabling member printed	Lord Turnberg
	uin	HL3054
	answer	answer is ministerial correction date of answer 04/12/2014 answer text <p>NHS England has advised that it is considering the recommendations in the Patient Charter which was published by Genetic Alliance UK on 21 October 2014.</p><p> </p><p> </p><p> </p><p>NHS England is working with stakeholders to review the process through which it develops commissioning policies. NHS England is also considering whether it may be appropriate to reduce the usual 12-week consultation period where a technology affects a very small number of patients who have been actively engaged in developing a commissioning policy and whose views have been taken into account during that development.</p><p> </p> answering member printed Earl Howe question first answered 04/12/2014 12:16:24 answering member 2000 label Biography information for Earl Howe
	tabling member	2537 label Biography information for Lord Turnberg

164227

	registered interest
	date	21/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	West Africa: Ebola
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what discussions they have had with the government of the Republic of Ireland on measures to deal with those passengers entering either that country or the United Kingdom from areas where ebola is at present widespread.
	tabling member printed	Lord Eames
	uin	HL3057
	answer	answer is ministerial correction date of answer 04/12/2014 answer text <p>Jane Ellison, Parliamentary under Secretary of State for Public Health, had a discussion with Leo Varadkar, the Irish Health Minister, on 30 October where they discussed a number of issues around Ebola. In addition, Dr John Watson, Deputy Chief Medical Officer, had a general discussion on Ebola with his Irish counterparts on 11 November.</p><p> </p><p> </p><p> </p><p>In addition, there are ongoing discussions at European Union level between officials in which both the Republic of Ireland and United Kingdom representatives participate.</p><p> </p> answering member printed Earl Howe grouped question UIN HL3058 question first answered 04/12/2014 16:01:11 answering member 2000 label Biography information for Earl Howe
	tabling member	2793 label Biography information for Lord Eames

164228

	registered interest
	date	21/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	West Africa: Ebola
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether they have had any discussions with the public health authorities in the Republic of Ireland regarding co-operation with health authorities in the United Kingdom on any threat to either jurisdiction by incoming passengers from areas where ebola is widespread at present; and if not, why not.
	tabling member printed	Lord Eames
	uin	HL3058
	answer	answer is ministerial correction date of answer 04/12/2014 answer text <p>Jane Ellison, Parliamentary under Secretary of State for Public Health, had a discussion with Leo Varadkar, the Irish Health Minister, on 30 October where they discussed a number of issues around Ebola. In addition, Dr John Watson, Deputy Chief Medical Officer, had a general discussion on Ebola with his Irish counterparts on 11 November.</p><p> </p><p> </p><p> </p><p>In addition, there are ongoing discussions at European Union level between officials in which both the Republic of Ireland and United Kingdom representatives participate.</p><p> </p> answering member printed Earl Howe grouped question UIN HL3057 question first answered 04/12/2014 16:01:11 answering member 2000 label Biography information for Earl Howe
	tabling member	2793 label Biography information for Lord Eames

164242

	registered interest
	date	21/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Alcoholic Drinks: Children
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether their partnership commitment to the Public Health Responsibility Deal prevents or inhibits them from halting the growth of sales of food infused with alcohol that can be sold to children under the age of 16.
	tabling member printed	Lord Brooke of Alverthorpe
	uin	HL3072
	answer	answer is ministerial correction date of answer 04/12/2014 answer text <p>Organisations signing up as partners to the Public Health Responsibility Deal commit voluntarily to play their part in improving public health. They lead the way in positively shaping and creating an environment that supports people to make informed, balanced choices and help them live healthier lives.</p><p> </p><p> </p><p> </p><p>Under the Licensing Act 2003, any food item infused with alcohol whose strength exceeds 0.5% at the time of sale is classed as alcohol and cannot be sold to children under the age of 18. The Act sets out a number of exemptions to this definition including liqueur confectionery, which is further defined by the Act.</p><p> </p><p> </p><p> </p><p>The Licensing Act 2003 requires licensed premises to operate an age verification policy. Through the Responsibility Deal, 68 companies, including 12 supermarket chains, have committed voluntarily to implement this requirement by ensuring effective action is taken in all their premises to reduce and prevent under-age sales of alcohol, by applying the standards set out in either the Challenge 21 or Challenge 25 schemes.</p><p> </p> answering member printed Earl Howe question first answered 04/12/2014 15:59:49 answering member 2000 label Biography information for Earl Howe
	tabling member	3335 label Biography information for Lord Brooke of Alverthorpe

164497

	registered interest
	date	24/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Stem Cells
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what proportion of the mitochondrial diseases listed in Annex D of the Mitochondrial Donation consultation document, February 2014, include degenerative neurological conditions; whether the Human Fertilisation and Embryology Authority (HFEA) has received any suggestions from either research licence holders or nominal licensees that stem cells derived by somatic cell nuclear transfer "are likely to carry very low levels of mtDNA mutation and are therefore likely to be suitable for therapeutic use" to "treat degenerative disease caused by mtDNA mutations" as described in Scientific Reports (DOI: 10.1038/srep03844); and what assessment they have made of the feasibility of treating neurological conditions associated with mitochondrial disease in this way in light of findings recently reported in the journal Cell Stem Cell (DOI: 10.1016/j.stem.2014.11.003) and the Proceedings of the National Academy of Sciences of the United States of America (Volume 111, no. 26, pages 9633–38).
	tabling member printed	Lord Alton of Liverpool
	uin	HL3090
	answer	answer is ministerial correction date of answer 04/12/2014 answer text <p>We are advised that all conditions listed in Annex D of the mitochondrial donation consultation document ultimately lead to progressive degenerative neurological conditions.</p><p> </p><p> </p><p> </p><p>The Human Fertilisation and Embryology Authority (HFEA) has advised that one of the research projects it licenses is investigating the use of embryonic stem cells “to improve the outcome of infertility treatments, and to make progress towards the wider application of IVF-based techniques to help prevent and treat degenerative disease”. The latest interim inspection report relating to this project can be found on the HFEA’s website at:</p><p> </p><p> </p><p> </p><p><a href="http://guide.hfea.gov.uk/guide/InspectionReport.aspx?code=17&amp;s=l&amp;&amp;nav=3" target="_blank">http://guide.hfea.gov.uk/guide/InspectionReport.aspx?code=17&amp;s=l&amp;&amp;nav=3</a></p><p> </p><p> </p><p> </p><p>The HFEA has also advised that it has not made the assessment stated by the noble Lord in respect of the two journal articles.</p><p> </p> answering member printed Earl Howe question first answered 04/12/2014 15:58:39 answering member 2000 label Biography information for Earl Howe
	tabling member	738 label Biography information for Lord Alton of Liverpool

164505

	registered interest
	date	24/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Diabetes
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of the impact of NHS England’s Action for Diabetes on the commissioning decisions made by clinical commissioning groups.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL3098
	answer	answer is ministerial correction date of answer 04/12/2014 answer text <p>It is for clinical commissioning groups (CCGs) to commission services that they assess are needed to meet the needs of their local populations. Action for Diabetes was published for CCGs, as a reference to the work that is going on across NHS England, and for the wider community interested in diabetes care, to show what action NHS England is taking in this important area.</p><p> </p> answering member printed Earl Howe question first answered 04/12/2014 12:20:06 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

164535

	registered interest
	date	24/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	General Practitioners: Pay
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, further to the Written Answer by Earl Howe on 5 November (HL2465), what is the amount of the enhanced payment for each of the 20 medical conditions listed.
	tabling member printed	Lord Stoddart of Swindon
	uin	HL3128
	answer	answer is ministerial correction date of answer 04/12/2014 answer text <p>The 20 medical conditions listed in the answer of 5 November (HL2465) relate to indicators in the Quality and Outcomes Framework (QOF). QOF is a voluntary incentive scheme that provides additional reward to general practitioner practices for how well they care for patients based on performance against a number of agreed indicators.</p><p> </p><p> </p><p> </p><p>Each indicator is assigned a number of QOF points, further detail is set out on the NHS Employers website:</p><p> </p><p> </p><p> </p><p>http://www.nhsemployers.org/your-workforce/primary-care-contacts/general-medical-services/quality-and-outcomes-framework</p><p> </p><p> </p><p> </p><p>QOF points are awarded according to level of achievement. In 2014-15 there is a possible total of 559 points. The value of each QOF point is set out in the Statement of Financial Entitlements and is currently £156.92. The final payment is weighted to take account of the practice population.</p><p> </p> answering member printed Earl Howe question first answered 04/12/2014 13:41:49 answering member 2000 label Biography information for Earl Howe
	tabling member	950 label Biography information for Lord Stoddart of Swindon

166097

	registered interest
	date	25/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health: Screening
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what percentage of the eligible population have been offered an appointment under the NHS Health Check Scheme for each year since the scheme began.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL3155
	answer	answer is ministerial correction date of answer 04/12/2014 answer text <p>Data on NHS Health Check offers has been collected nationally since 2011-12. In 2011-12 and 2012-13 14% and 16.5% of eligible people were offered an NHS Health Check respectively. In 2013/14 the programme became a mandatory service with all local authorities delivering it and 18.4% of the eligible population was offered an NHS Health Check. The data for the programme is published each quarter for the 152 local authorities responsible for providing this service on:</p><p> </p><p> </p><p> </p><p><a href="http://www.healthierlives.phe.org.uk/" target="_blank">www.healthierlives.phe.org.uk</a></p><p> </p> answering member printed Earl Howe question first answered 04/12/2014 15:57:39 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath